SEC Form 4 · accession 0001104659-16-143564
BIOTELEMETRY, INC. · BEAT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Peter Ferola
Officer — General Counsel
Period of report
Sep 2, 2016
Accepted (ET)
Sep 7, 2016 · 7:32 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001574774
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Sep 2, 2016 | S | 3,615 | $18.75 | D | 26,637 | D | |
| Common Stock | Sep 2, 2016 | M | 1,241 | $2.54 | A | 27,878 | D | |
| Common StockF2 | Sep 2, 2016 | S | 1,241 | $18.75 | D | 26,637 | D | |
| Common Stock | Sep 6, 2016 | M | 4,960 | $2.54 | A | 31,597 | D | |
| Common StockF3 | Sep 6, 2016 | S | 4,960 | $18.29 | D | 26,637 | D | |
| Common Stock | Sep 7, 2016 | M | 4,237 | $2.54 | A | 30,874 | D | |
| Common StockF4 | Sep 7, 2016 | S | 4,237 | $18.52 | D | 26,637 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (Right to Buy)F5 | $2.54 | Sep 2, 2016 | M | 1,241 | D | — | Feb 19, 2023 | Common Stock | 1,241 | 25,866 | D |
| Stock Options (Right to Buy)F5 | $2.54 | Sep 6, 2016 | M | 4,960 | D | — | Feb 19, 2023 | Common Stock | 4,960 | 20,906 | D |
| Stock Options (Right to Buy)F6 | $2.54 | Sep 7, 2016 | M | 4,237 | D | — | Feb 19, 2023 | Common Stock | 4,237 | 16,669 | D |
Explanation of responses
- F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 5, 2016.
- F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $18.60 to $18.91, inclusive. The reporting person undertakes to provide to BioTelemetry, Inc., any security holder of BioTelemetry, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 to this Form 4.
- F3This price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.00 to $18.90, inclusive.
- F4This price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.31 to $18.63, inclusive.
- F5These options became exercisable on December 31, 2013.
- F6576 of these options became exercisable on December 31, 2013 and the remaining 3,661 of these options became exercisable on December 31, 2014.